Scott Kathleen D.

Scott Kathleen D. is listed in filings as Chief Financial Officer at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY), NKGen Biotech, Inc. Warrants (NKGNW), and NKGen Biotech, Inc. Common Stock (NKGN). The current snapshot covers public activity from Aug 21, 2024 to Jan 5, 2026. Reported amounts are shown as $200.0K to $1.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.